These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11727179

  • 1. Transdermal contraception.
    Creasy GW, Abrams LS, Fisher AC.
    Semin Reprod Med; 2001 Dec; 19(4):373-80. PubMed ID: 11727179
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic overview of Ortho Evra/Evra.
    Abrams LS, Skee D, Natarajan J, Wong FA.
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
    [Abstract] [Full Text] [Related]

  • 3. The transdermal contraceptive patch: a new approach to hormonal contraception.
    Burkman RT.
    Int J Fertil Womens Med; 2002 Feb; 47(2):69-76. PubMed ID: 11991433
    [Abstract] [Full Text] [Related]

  • 4. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
    Goa KL, Warner GT, Easthope SE.
    Treat Endocrinol; 2003 Feb; 2(3):191-206. PubMed ID: 15966567
    [Abstract] [Full Text] [Related]

  • 5. [Transdermal contraception--a new beginning].
    Sigridov I, Dikov I, Ivanov S.
    Akush Ginekol (Sofiia); 2004 Feb; 43 Suppl 1():19-27. PubMed ID: 15323313
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [Abstract] [Full Text] [Related]

  • 8. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR, Loomba PK.
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S, Kaye JA, Li L, Jick H.
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [Abstract] [Full Text] [Related]

  • 12. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ.
    Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
    [Abstract] [Full Text] [Related]

  • 15. Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system.
    Sriprasert I, Stanczyk FZ, Archer DF.
    Expert Opin Pharmacother; 2015 Jun; 16(12):1901-9. PubMed ID: 26194214
    [Abstract] [Full Text] [Related]

  • 16. Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
    White T, Jain JK, Stanczyk FZ.
    Am J Obstet Gynecol; 2005 Jun; 192(6):2055-9. PubMed ID: 15970897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.